vs

Side-by-side financial comparison of Genius Group Ltd (GNS) and Opus Genetics, Inc. (IRD). Click either name above to swap in a different company.

Genius Group Ltd is the larger business by last-quarter revenue ($7.6M vs $3.9M, roughly 2.0× Opus Genetics, Inc.).

Genius is an American digital media company founded on August 27, 2009, by Tom Lehman, Ilan Zechory, and Mahbod Moghadam. The company's eponymous website serves as a database for song lyrics, news stories, sources, poetry, and documents, in which users can provide annotations and interpretations for.

Opus Genetics, Inc. is a clinical-stage biotechnology company specializing in the development of targeted gene therapies for inherited retinal diseases. It focuses on addressing unmet medical needs for patients living with rare, vision-threatening ocular conditions, with operations centered on advancing accessible therapeutic candidates for global rare disease patient populations.

GNS vs IRD — Head-to-Head

Bigger by revenue
GNS
GNS
2.0× larger
GNS
$7.6M
$3.9M
IRD

Income Statement — Q4 FY2024 vs Q4 FY2025

Metric
GNS
GNS
IRD
IRD
Revenue
$7.6M
$3.9M
Net Profit
$-24.9M
Gross Margin
31.0%
Operating Margin
-281.9%
Net Margin
-328.9%
Revenue YoY
-10.2%
Net Profit YoY
53.0%
EPS (diluted)
$-1.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GNS
GNS
IRD
IRD
Q4 25
$3.9M
Q3 25
$3.1M
Q2 25
$2.9M
Q1 25
$7.6M
$4.4M
Q4 24
$4.3M
Q3 24
$3.9M
Q2 24
$1.1M
Q1 24
$1.7M
Net Profit
GNS
GNS
IRD
IRD
Q4 25
Q3 25
$-17.5M
Q2 25
$-7.4M
Q1 25
$-24.9M
$-8.2M
Q4 24
Q3 24
$-7.5M
Q2 24
$-7.8M
Q1 24
$-7.1M
Gross Margin
GNS
GNS
IRD
IRD
Q4 25
Q3 25
Q2 25
Q1 25
31.0%
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
GNS
GNS
IRD
IRD
Q4 25
Q3 25
-269.9%
Q2 25
-309.0%
Q1 25
-281.9%
-227.2%
Q4 24
Q3 24
-207.1%
Q2 24
-748.9%
Q1 24
-450.5%
Net Margin
GNS
GNS
IRD
IRD
Q4 25
Q3 25
-566.9%
Q2 25
-257.5%
Q1 25
-328.9%
-187.5%
Q4 24
Q3 24
-194.6%
Q2 24
-698.3%
Q1 24
-415.3%
EPS (diluted)
GNS
GNS
IRD
IRD
Q4 25
Q3 25
$-0.25
Q2 25
$-0.12
Q1 25
$-1.03
$-0.24
Q4 24
Q3 24
$-0.29
Q2 24
$-0.30
Q1 24
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GNS
GNS
IRD
IRD
Cash + ST InvestmentsLiquidity on hand
$1.6M
$45.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$79.4M
$15.3M
Total Assets
$101.1M
$50.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GNS
GNS
IRD
IRD
Q4 25
$45.1M
Q3 25
$30.8M
Q2 25
$32.4M
Q1 25
$1.6M
$41.8M
Q4 24
$30.3M
Q3 24
$36.6M
Q2 24
$41.4M
Q1 24
$47.2M
Stockholders' Equity
GNS
GNS
IRD
IRD
Q4 25
$15.3M
Q3 25
$6.0M
Q2 25
$17.5M
Q1 25
$79.4M
$5.1M
Q4 24
$6.7M
Q3 24
$34.3M
Q2 24
$40.6M
Q1 24
$46.1M
Total Assets
GNS
GNS
IRD
IRD
Q4 25
$50.2M
Q3 25
$36.1M
Q2 25
$38.7M
Q1 25
$101.1M
$48.2M
Q4 24
$36.9M
Q3 24
$40.4M
Q2 24
$44.8M
Q1 24
$51.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GNS
GNS
IRD
IRD
Operating Cash FlowLast quarter
$-46.3M
$-35.3M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GNS
GNS
IRD
IRD
Q4 25
$-35.3M
Q3 25
$-6.2M
Q2 25
$-10.3M
Q1 25
$-46.3M
$-9.0M
Q4 24
$-25.6M
Q3 24
$-5.1M
Q2 24
$-7.3M
Q1 24
$-5.7M

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons